Veru Announces Publication of Data on Oral VERU-111 in Prostate Cancer in Connection with the 2018 American Society of Clinical Oncology Annual Meeting

World News: . []

MIAMI May 17 2018 GLOBE NEWSWIRE -- Veru Inc NASDAQ VERU a urology and oncology biopharmaceutical company today announced the publication of data from preclinical studies of VERU-111 a novel oral alpha and beta tubulin inhibitor showi ng pote...

More news and information about Veru Inc.

Published By:

Globe Newswire: 13:15 GMT Thursday 17th May 2018

Published: .

Search for other references to "veru" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us